Market Tracker

10/24 2:02pm ET

Immunomedics Inc (NASDAQ:IMMU)

3.77
Data as of 1:47pm ET
 +0.005 / +0.13%
Today’s Change
3.04
Today|||52-Week Range
6.17
-18.15%
Year-to-Date

Today’s Trading

Previous close3.76
Today’s open3.77
Day’s range3.72 - 3.83
Volume250,200
Average volume (3 months)623,315
Market cap$350.2M
Dividend yield--
Data as of 1:47pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)-162.50%
Earnings growth (this year)-8.73%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+82.22%
P/E ratioNM
Price/Sales34.16
Price/Book8.89

Competitors

 Today’s
change
Today’s
% change
LMNSLumenis Ltd+0.02+0.25%
IVCInvacare Corp+2.16+16.44%
ARDXArdelyx Inc-1.57-6.83%
CYNOCynosure Inc-0.22-1.05%
Data as of 2:01pm ET, 10/24/2014

Financials

Next reporting dateNovember 6, 2014
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$9.0M
Annual profit (last year)-$35.4M
Net profit margin-391.81%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Medical Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts